144 related articles for article (PubMed ID: 22464883)
1. Relative imbalances in the expression of catechol-O-methyltransferase and cytochrome P450 in breast cancer tissue and their association with breast carcinoma.
Zhao YN; Zhang W; Chen YC; Fang F; Liu XQ
Maturitas; 2012 Jun; 72(2):139-45. PubMed ID: 22464883
[TBL] [Abstract][Full Text] [Related]
2. Expression of cytochrome P450 1B1 and catechol-O-methyltransferase in breast tissue and their associations with breast cancer risk.
Wen W; Ren Z; Shu XO; Cai Q; Ye C; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):917-20. PubMed ID: 17507616
[TBL] [Abstract][Full Text] [Related]
3. Relative imbalances in the expression of estrogen-metabolizing enzymes in the breast tissue of women with breast carcinoma.
Singh S; Chakravarti D; Edney JA; Hollins RR; Johnson PJ; West WW; Higginbotham SM; Cavalieri EL; Rogan EG
Oncol Rep; 2005 Oct; 14(4):1091-6. PubMed ID: 16142378
[TBL] [Abstract][Full Text] [Related]
4. Phytoestrogens modulate the expression of 17alpha-estradiol metabolizing enzymes in cultured MCF-7 cells.
Wagner J; Jiang L; Lehmann L
Adv Exp Med Biol; 2008; 617():625-32. PubMed ID: 18497090
[TBL] [Abstract][Full Text] [Related]
5. 12-O-tetradecanoylphorbol-13-acetate upregulates the Ah receptor and differentially alters CYP1B1 and CYP1A1 expression in MCF-7 breast cancer cells.
Spink BC; Fasco MJ; Gierthy JF; Spink DC
J Cell Biochem; 1998 Sep; 70(3):289-96. PubMed ID: 9706865
[TBL] [Abstract][Full Text] [Related]
6. A methoxyflavonoid, chrysoeriol, selectively inhibits the formation of a carcinogenic estrogen metabolite in MCF-7 breast cancer cells.
Takemura H; Uchiyama H; Ohura T; Sakakibara H; Kuruto R; Amagai T; Shimoi K
J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):70-6. PubMed ID: 19833205
[TBL] [Abstract][Full Text] [Related]
7. Interactions between genetic polymorphism of cytochrome P450-1B1, sulfotransferase 1A1, catechol-o-methyltransferase and tobacco exposure in breast cancer risk.
Saintot M; Malaveille C; Hautefeuille A; Gerber M
Int J Cancer; 2003 Nov; 107(4):652-7. PubMed ID: 14520706
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical evaluation of cytochrome P450 (CYP) and p53 in breast cancer.
Oyama T; Morita M; Isse T; Kagawa N; Nakata S; So T; Mizukami M; Ichiki Y; Ono K; Sugaya M; Uramoto H; Yoshimatsu T; Hanagiri T; Sugio K; Kawamoto T; Yasumoto K
Front Biosci; 2005 May; 10():1156-61. PubMed ID: 15769614
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P450 1B1 and catechol-O-methyltransferase genetic polymorphisms and breast cancer risk in Chinese women: results from the shanghai breast cancer study and a meta-analysis.
Wen W; Cai Q; Shu XO; Cheng JR; Parl F; Pierce L; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):329-35. PubMed ID: 15734954
[TBL] [Abstract][Full Text] [Related]
10. Role of human cytochrome P450 1A1, 1A2, 1B1, and 3A4 in the 2-, 4-, and 16alpha-hydroxylation of 17beta-estradiol.
Badawi AF; Cavalieri EL; Rogan EG
Metabolism; 2001 Sep; 50(9):1001-3. PubMed ID: 11555828
[TBL] [Abstract][Full Text] [Related]
11. Regulation of cancer-related genes - Cyp1a1, Cyp1b1, Cyp19, Nqo1 and Comt - expression in β-naphthoflavone-treated mice by miroestrol.
Chatuphonprasert W; Jarukamjorn K; Putalun W
J Pharm Pharmacol; 2016 Apr; 68(4):475-84. PubMed ID: 26893163
[TBL] [Abstract][Full Text] [Related]
12. Genetic modelling of the estrogen metabolism as a risk factor of hormone-dependent disorders.
Huber JC; Schneeberger C; Tempfer CB
Maturitas; 2002 May; 42(1):1-12. PubMed ID: 12020974
[TBL] [Abstract][Full Text] [Related]
13. Soy isoflavones, CYP1A1, CYP1B1, and COMT polymorphisms, and breast cancer: a case-control study in southwestern China.
Wang Q; Li H; Tao P; Wang YP; Yuan P; Yang CX; Li JY; Yang F; Lee H; Huang Y
DNA Cell Biol; 2011 Aug; 30(8):585-95. PubMed ID: 21438753
[TBL] [Abstract][Full Text] [Related]
14. Effects of zearalenone on mRNA expression and activity of cytochrome P450 1A1 and 1B1 in MCF-7 cells.
Yu Z; Hu D; Li Y
Ecotoxicol Environ Saf; 2004 Jun; 58(2):187-93. PubMed ID: 15157572
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in genes involved in the estrogen pathway and mammographic density.
Dumas I; Diorio C
BMC Cancer; 2010 Nov; 10():636. PubMed ID: 21092186
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome p450 and glutathione transferase expression in human breast cancer.
El-Rayes BF; Ali S; Heilbrun LK; Lababidi S; Bouwman D; Visscher D; Philip PA
Clin Cancer Res; 2003 May; 9(5):1705-9. PubMed ID: 12738724
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 CYP1B1 and catechol O-methyltransferase (COMT) genetic polymorphisms and breast cancer susceptibility in a Turkish population.
Kocabaş NA; Sardaş S; Cholerton S; Daly AK; Karakaya AE
Arch Toxicol; 2002 Nov; 76(11):643-9. PubMed ID: 12415427
[TBL] [Abstract][Full Text] [Related]
18. CYP450- and COMT-derived estradiol metabolites inhibit activity of human coronary artery SMCs.
Dubey RK; Gillespie DG; Zacharia LC; Barchiesi F; Imthurn B; Jackson EK
Hypertension; 2003 Mar; 41(3 Pt 2):807-13. PubMed ID: 12624000
[TBL] [Abstract][Full Text] [Related]
19. Methoxyestrogens exert feedback inhibition on cytochrome P450 1A1 and 1B1.
Dawling S; Roodi N; Parl FF
Cancer Res; 2003 Jun; 63(12):3127-32. PubMed ID: 12810639
[TBL] [Abstract][Full Text] [Related]
20. Gene expression of 17beta-estradiol-metabolizing isozymes: comparison of normal human mammary gland to normal human liver and to cultured human breast adenocarcinoma cells.
Lehmann L; Wagner J
Adv Exp Med Biol; 2008; 617():617-24. PubMed ID: 18497089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
